Related Experiment Video
Updated: Nov 8, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Paediatric research in the times of COVID-19
Paul F Fleming1,2, Chris Gale3,4, Eleanor J Molloy5,6,7
1Homerton University Hospital, NHS Foundation Trust, London, UK.
Insights
The COVID-19 pandemic impacts children's health research, necessitating streamlined, collaborative approaches. Ensuring children's early inclusion in trials is crucial for future pediatric health advancements.
Area of Science:
- Pediatric Health Research
- Infectious Disease Epidemiology
- Global Health Policy
Background:
- The COVID-19 pandemic presents significant challenges to pediatric health research, affecting trial participation and funding.
- Disruptions caused by the pandemic necessitate adaptive strategies for ongoing and future research endeavors.
- Economic downturns may further impact the financial resources available for crucial child health studies.
Purpose of the Study:
- To outline the direct and indirect consequences of the COVID-19 pandemic on children's health research.
- To emphasize the importance of collaborative, networked, and technologically advanced research methods.
- To provide recommendations for optimizing research governance, data sharing, and trial design for pediatric populations.
Main Methods:
- Review of pandemic-related impacts on pediatric research activities.
- Analysis of collaborative research models and remote technologies in clinical trials.
- Synthesis of expert recommendations for research governance and trial development.
Main Results:
- Streamlined research processes and remote technologies have been vital in mitigating COVID-19's impact.
- Collaborative and networked research efforts have proven essential for reducing morbidity and mortality.
- The pandemic highlights the need for efficient research governance and data sharing.
Conclusions:
- Maintaining efficient research governance and data sharing is critical for high-quality collaborative research.
- Early inclusion of children in relevant therapeutic trials is imperative.
- Paediatric Research Societies must coordinate multinational trials for diagnostics, therapeutics, and preventative strategies.
Abstract:
The COVID-19 pandemic poses many direct and indirect consequences for children's health and associated research. Direct consequences include participation of children in COVID-19 research trials, pausing other research in children and the potential implications of a global economic downturn on future research funding. Collaborative and networked research together with streamlined research processes and use of remote technology have been central to efforts by clinicians and scientists around the world and have proved essential for reducing COVID-19 morbidity and mortality. IMPACT: Maintain streamlined and efficient approaches to research governance and data sharing to facilitate high-quality collaborative research. Ensure early inclusion of children in trials of therapies for diseases that affect all age groups. Paediatric Research Societies should co-ordinate effective processes to define key research questions and develop multinational clinical trials for diagnostics, therapeutics and preventative strategies for infants, children and young people.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Drug Dosing: Infants and Children
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...

